Otonomy in brief
Otonomy is an unlisted company in the Biotechnology industry, based in California, USA. It was founded in 2008. In the year to Dec 2020 it had sales of $0 M and a net loss of $45 M.
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Otonomy timeline
- 2008
- 🏁· approximateFounded
- 2014
- 🔔· approximateInitial public offering on Nasdaq
Events of Otonomy from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about Otonomy
- Acquisitions and changes
- No longer listed: ticker OTIC is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
World rank over time
Rank in USA: #3,461 (Jan 2020) · #3,004 (Jan 2021) · #4,314 (Jan 2022)
Annual results
- Revenue
- $0 M
- Operating income
- —
- Net income
- $-45 M
Dec-2020 ending year
How Otonomy compares in Biotechnology
- Revenue$0 M · higher than 19% of 647
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Otonomy🇺🇸 | $113 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jan 7, 2022 (last known)
- Annual results:
- Dec-2020 ending year
- Balance sheet:
- Dec-2020 ending year
- Profile updated:
- Nov 14, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Otonomy? Verify and update this profile — free
Show Otonomy's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.